Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
Sepideh Paybast, Mohammad Amin Habibi, Abdorreza Naser Moghadasi
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Multiple sclerosisMedicineFingolimodNeurologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicInternal medicine2019-20 coronavirus outbreakOutbreakDiseaseImmunologyPsychiatryVirologyInfectious disease (medical specialty)Multiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19